Work

Role of the Glucagon and Glucagon-like Peptides in Pancreatic Beta Cell and Cardiovascular Function

Year: 2014
Type: dissertation
Abstract: Glucagon is inappropriately elevated in diabetes, and inhibition of glucagon receptor (Gcgr) signaling is beneficial for glycemic control. However, the mechanism through which inhibition of Gcgr signaling leads to improved glycemic control is unknown. Additionally, Gcgr is expressed in the cardiovascular system; however the role of Gcgr signaling in the cardiovascular system is unexplored. In order to develop therapies targeting Gcgr signaling for the treatment of type 2 diabetes (T2D) it is vital to understand Gcgr' s role in regulation of glucose homeostasis and cardiovascular function. In mice, genetic deletion of the glucagon receptor results in increased levels of the insulinotropic hormone, glucagon-like peptide-1 (GLP-1). I hypothesized Glp1r signaling contributed substantially to the improved glucose tolerance observed in Gcgr-/- mice. I have generated and characterized the Gcgr and Glp-1 receptor double knockout (Gcgr-/-:Glp1r-/-) mice. My studies demonstrate that Glp1r substantially contributes to the delayed gastric emptying and improved intraperitoneal glucose tolerance in Gcgr-/- mice, but it did not contribute to the improved oral glucose tolerance seen in the Gcgr-/- mice. Interestingly, expression of non-classical incretin receptors and sensitivity to their exogenous agonists were increased in Gcgr-/-:Glp1r-/- mice, suggesting that in the absence of the classical incretin receptors the non-classical incretin receptors compensate to maintain the enteroinsular axis. I explored the role of Gcgr signaling in the cardiovascular system under normal and ischemic conditions. My studies showed that exogenous glucagon increased mortality from myocardial infarction in WT mice in a p38 MAPK-dependent manner. Conversely, Gcgr+/- and cardiac specific Gcgr-/- mice (GcgrCM-/-) had improved survival following myocardial infarction. Gene expression profiling of hearts from GcgrCM-/- mice showed reduced expression of fatty acid oxidation gene, consistent with a reduction in long-chain acylcarnitines observed upon metabolic profiling of GcgrCM-/- hearts. Therefore, partial or cardiomyocyte specific loss of Gcgr signaling enhanced protection to ischemic injury by regulating fatty acid oxidation. In conclusion, my studies suggest Gcgr signaling is essential for beta cell nutrient sensing and fuel metabolism in cardiomyocytes and therapies aiming at modulating Gcgr signaling for the treatment of T2D require careful assessment of cardiovascular outcomes.
Author: Safina Ali
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2597575204
Cites: 134
Cited by:
Related to: 10